Peripheral Artery Revascularisation - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510245582

Publication Date:

October 29, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Peripheral arteries are blood vessels that carry blood from the heart to the arms, legs and other organs apart from the brain and heart. Peripheral artery disease is the most common form of peripheral vessels disease. Peripheral artery revascularisation is required when blood is not supplied efficiently to peripheral organs.听
The global market for Peripheral Artery Revascularisation was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Peripheral Artery Revascularisation, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Peripheral Artery Revascularisation by region & country, by Type, and by Application.
The Peripheral Artery Revascularisation market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Artery Revascularisation.
麻豆原创 Segmentation
By Company
Abbott Laboratories
Medtronic
AngioDynamics
C. R. Bard
Terumo Corporation
Boston Scientific Corporation
Cook Medical
Cardinal Health
Philips Healthcare
Segment by Type:
Lower Extremity Revascularisation
Renal Arterial Revascularisation
Mesenteric Arterial Revascularisation
Abdominal Aortic Revascularisation
Others
Segment by Application
Hospitals
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Peripheral Artery Revascularisation manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Peripheral Artery Revascularisation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Peripheral Artery Revascularisation in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Peripheral Artery Revascularisation Product Introduction
1.2 Global Peripheral Artery Revascularisation 麻豆原创 Size Forecast
1.3 Peripheral Artery Revascularisation 麻豆原创 Trends & Drivers
1.3.1 Peripheral Artery Revascularisation Industry Trends
1.3.2 Peripheral Artery Revascularisation 麻豆原创 Drivers & Opportunity
1.3.3 Peripheral Artery Revascularisation 麻豆原创 Challenges
1.3.4 Peripheral Artery Revascularisation 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Peripheral Artery Revascularisation Players Revenue Ranking (2023)
2.2 Global Peripheral Artery Revascularisation Revenue by Company (2019-2024)
2.3 Key Companies Peripheral Artery Revascularisation Manufacturing Base Distribution and Headquarters
2.4 Key Companies Peripheral Artery Revascularisation Product Offered
2.5 Key Companies Time to Begin Mass Production of Peripheral Artery Revascularisation
2.6 Peripheral Artery Revascularisation 麻豆原创 Competitive Analysis
2.6.1 Peripheral Artery Revascularisation 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Peripheral Artery Revascularisation Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Artery Revascularisation as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Lower Extremity Revascularisation
3.1.2 Renal Arterial Revascularisation
3.1.3 Mesenteric Arterial Revascularisation
3.1.4 Abdominal Aortic Revascularisation
3.1.5 Others
3.2 Global Peripheral Artery Revascularisation Sales Value by Type
3.2.1 Global Peripheral Artery Revascularisation Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Peripheral Artery Revascularisation Sales Value, by Type (2019-2030)
3.2.3 Global Peripheral Artery Revascularisation Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Specialty Clinics
4.1.3 Others
4.2 Global Peripheral Artery Revascularisation Sales Value by Application
4.2.1 Global Peripheral Artery Revascularisation Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Peripheral Artery Revascularisation Sales Value, by Application (2019-2030)
4.2.3 Global Peripheral Artery Revascularisation Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Peripheral Artery Revascularisation Sales Value by Region
5.1.1 Global Peripheral Artery Revascularisation Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Peripheral Artery Revascularisation Sales Value by Region (2019-2024)
5.1.3 Global Peripheral Artery Revascularisation Sales Value by Region (2025-2030)
5.1.4 Global Peripheral Artery Revascularisation Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Peripheral Artery Revascularisation Sales Value, 2019-2030
5.2.2 North America Peripheral Artery Revascularisation Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Peripheral Artery Revascularisation Sales Value, 2019-2030
5.3.2 Europe Peripheral Artery Revascularisation Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Peripheral Artery Revascularisation Sales Value, 2019-2030
5.4.2 Asia Pacific Peripheral Artery Revascularisation Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Peripheral Artery Revascularisation Sales Value, 2019-2030
5.5.2 South America Peripheral Artery Revascularisation Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Peripheral Artery Revascularisation Sales Value, 2019-2030
5.6.2 Middle East & Africa Peripheral Artery Revascularisation Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Peripheral Artery Revascularisation Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Peripheral Artery Revascularisation Sales Value
6.3 United States
6.3.1 United States Peripheral Artery Revascularisation Sales Value, 2019-2030
6.3.2 United States Peripheral Artery Revascularisation Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Peripheral Artery Revascularisation Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Peripheral Artery Revascularisation Sales Value, 2019-2030
6.4.2 Europe Peripheral Artery Revascularisation Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Peripheral Artery Revascularisation Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Peripheral Artery Revascularisation Sales Value, 2019-2030
6.5.2 China Peripheral Artery Revascularisation Sales Value by Type (%), 2023 VS 2030
6.5.3 China Peripheral Artery Revascularisation Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Peripheral Artery Revascularisation Sales Value, 2019-2030
6.6.2 Japan Peripheral Artery Revascularisation Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Peripheral Artery Revascularisation Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Peripheral Artery Revascularisation Sales Value, 2019-2030
6.7.2 South Korea Peripheral Artery Revascularisation Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Peripheral Artery Revascularisation Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Peripheral Artery Revascularisation Sales Value, 2019-2030
6.8.2 Southeast Asia Peripheral Artery Revascularisation Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Peripheral Artery Revascularisation Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Peripheral Artery Revascularisation Sales Value, 2019-2030
6.9.2 India Peripheral Artery Revascularisation Sales Value by Type (%), 2023 VS 2030
6.9.3 India Peripheral Artery Revascularisation Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories Peripheral Artery Revascularisation Products, Services and Solutions
7.1.4 Abbott Laboratories Peripheral Artery Revascularisation Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 Medtronic
7.2.1 Medtronic Profile
7.2.2 Medtronic Main Business
7.2.3 Medtronic Peripheral Artery Revascularisation Products, Services and Solutions
7.2.4 Medtronic Peripheral Artery Revascularisation Revenue (US$ Million) & (2019-2024)
7.2.5 Medtronic Recent Developments
7.3 AngioDynamics
7.3.1 AngioDynamics Profile
7.3.2 AngioDynamics Main Business
7.3.3 AngioDynamics Peripheral Artery Revascularisation Products, Services and Solutions
7.3.4 AngioDynamics Peripheral Artery Revascularisation Revenue (US$ Million) & (2019-2024)
7.3.5 C. R. Bard Recent Developments
7.4 C. R. Bard
7.4.1 C. R. Bard Profile
7.4.2 C. R. Bard Main Business
7.4.3 C. R. Bard Peripheral Artery Revascularisation Products, Services and Solutions
7.4.4 C. R. Bard Peripheral Artery Revascularisation Revenue (US$ Million) & (2019-2024)
7.4.5 C. R. Bard Recent Developments
7.5 Terumo Corporation
7.5.1 Terumo Corporation Profile
7.5.2 Terumo Corporation Main Business
7.5.3 Terumo Corporation Peripheral Artery Revascularisation Products, Services and Solutions
7.5.4 Terumo Corporation Peripheral Artery Revascularisation Revenue (US$ Million) & (2019-2024)
7.5.5 Terumo Corporation Recent Developments
7.6 Boston Scientific Corporation
7.6.1 Boston Scientific Corporation Profile
7.6.2 Boston Scientific Corporation Main Business
7.6.3 Boston Scientific Corporation Peripheral Artery Revascularisation Products, Services and Solutions
7.6.4 Boston Scientific Corporation Peripheral Artery Revascularisation Revenue (US$ Million) & (2019-2024)
7.6.5 Boston Scientific Corporation Recent Developments
7.7 Cook Medical
7.7.1 Cook Medical Profile
7.7.2 Cook Medical Main Business
7.7.3 Cook Medical Peripheral Artery Revascularisation Products, Services and Solutions
7.7.4 Cook Medical Peripheral Artery Revascularisation Revenue (US$ Million) & (2019-2024)
7.7.5 Cook Medical Recent Developments
7.8 Cardinal Health
7.8.1 Cardinal Health Profile
7.8.2 Cardinal Health Main Business
7.8.3 Cardinal Health Peripheral Artery Revascularisation Products, Services and Solutions
7.8.4 Cardinal Health Peripheral Artery Revascularisation Revenue (US$ Million) & (2019-2024)
7.8.5 Cardinal Health Recent Developments
7.9 Philips Healthcare
7.9.1 Philips Healthcare Profile
7.9.2 Philips Healthcare Main Business
7.9.3 Philips Healthcare Peripheral Artery Revascularisation Products, Services and Solutions
7.9.4 Philips Healthcare Peripheral Artery Revascularisation Revenue (US$ Million) & (2019-2024)
7.9.5 Philips Healthcare Recent Developments
8 Industry Chain Analysis
8.1 Peripheral Artery Revascularisation Industrial Chain
8.2 Peripheral Artery Revascularisation Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Peripheral Artery Revascularisation Sales Model
8.5.2 Sales Channel
8.5.3 Peripheral Artery Revascularisation Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Abbott Laboratories
Medtronic
AngioDynamics
C. R. Bard
Terumo Corporation
Boston Scientific Corporation
Cook Medical
Cardinal Health
Philips Healthcare

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.